Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate effect on end-tidal CO2 and pain
IRCT20210302050549N1Phase 3Completed
- Sponsor
- Rafsanjan University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of magnesium sulfate in pain, sponsored by Rafsanjan University of Medical Sciences. Primary endpoints: Change in end-tidal CO2 and Pain outcomes. Started Apr 2021; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
pain
Beyond the preview
Go deeper on IRCT20210302050549N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210302050549N1.